(Q35689015)

9 August 2017

1 reference

title

Antibodies in scleroderma: direct pathogenicity and phenotypic associations (English)

1 reference

9 August 2017

Lorinda Chung

1

1 reference

9 August 2017

Paul J Utz

series ordinal

2

1 reference

9 August 2017

publication date

1 April 2004

1 reference

Current Rheumatology Reports

9 August 2017

published in

1 reference

9 August 2017

volume

6

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

156-163

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-004-0061-9

9 August 2017

exact match

0 references

cites work

Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-004-0061-9

A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement

21 January 2018

1 reference

12 December 2020

Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases

1 reference

12 December 2020

Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis.

1 reference

12 December 2020

Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis

1 reference

12 December 2020

Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension.

1 reference

12 December 2020

Antibodies to beta2 glycoprotein I and cardiolipin in SSc

1 reference

12 December 2020

Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis

1 reference

12 December 2020

Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies

1 reference

12 December 2020

Quantitative genetic variation in CD19 expression correlates with autoimmunity

1 reference

12 December 2020

More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosis

1 reference

12 December 2020

Autoantibody to th ribonucleoprotein (nucleolar 7–2 rna protein particle) in patients with systemic sclerosis

1 reference

12 December 2020

The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma

1 reference

12 December 2020

Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies

1 reference

12 December 2020

[Anti-neutrophil cytoplasmic autoantibody-associated rapid progressive glomerulonephritis complicated with both limited and diffuse scleroderma]

1 reference

12 December 2020

Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis

1 reference

12 December 2020

The Association of Primary Biliary Cirrhosis and Systemic Sclerosis is not Accounted for by Cross Reactivity Between Mitochondrial and Centromere Antigens

1 reference

12 December 2020

Correlation of serum anti‐DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis

1 reference

12 December 2020

Autoantibodies directed to novel components of the PM/Scl complex, the human exosome

1 reference

12 December 2020

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event

1 reference

12 December 2020

Clinicolaboratory characteristics of patients with primary biliary cirrhosis associated with CREST symptoms

1 reference

12 December 2020

Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension

1 reference

12 December 2020

The cytoplasmic linker protein CLIP-170 is a human autoantigen

1 reference

12 December 2020

The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis.

1 reference

12 December 2020

Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations

1 reference

12 December 2020

Antineutrophil cytoplasmic antibodies a "Red Flag" in patients with systemic sclerosis

1 reference

12 December 2020

The frequency and significance of anticardiolipin antibodies in scleroderma

1 reference

12 December 2020

Anti-c-Mpl (thrombopoietin receptor) autoantibody-induced amegakaryocytic thrombocytopenia in a patient with systemic sclerosis

1 reference

12 December 2020

Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay

1 reference

12 December 2020

Scleroderma overlap syndromes

1 reference

12 December 2020

In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay

1 reference

12 December 2020

CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse

1 reference

12 December 2020

Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles

1 reference

12 December 2020

Identity of the RNase MRP- and RNase P-associated Th/To autoantigen

1 reference

12 December 2020

Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement

1 reference

12 December 2020

Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations

1 reference

12 December 2020

Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis

1 reference

12 December 2020

Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex

1 reference

12 December 2020

Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis

1 reference

12 December 2020

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

1 reference

12 December 2020

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

1 reference

12 December 2020

Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss

1 reference

12 December 2020

Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings

1 reference

12 December 2020

Microscopic polyangiitis presenting as pulmonary-renal syndrome in a patient with long-standing diffuse cutaneous systemic sclerosis and antibodies to myeloperoxidase

1 reference

12 December 2020

Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma)

1 reference

12 December 2020

Autoantibodies to mitochondria in systemic sclerosis. Frequency and characterization using recombinant cloned autoantigen

1 reference

12 December 2020

The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis

1 reference

12 December 2020

Measurement of anticardiolipin antibodies by ELISA using beta 2-glycoprotein I (beta 2-GPI) in systemic sclerosis

1 reference

12 December 2020

10.1007/S11926-004-0061-9

Identifiers

DOI

1 reference

9 August 2017

1 reference